Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tia Gordon"'
Autor:
Tara N. Yankee, Sungryong Oh, Emma Wentworth Winchester, Andrea Wilderman, Kelsey Robinson, Tia Gordon, Jill A. Rosenfeld, Jennifer VanOudenhove, Daryl A. Scott, Elizabeth J. Leslie, Justin Cotney
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-23 (2023)
Abstract Craniofacial disorders arise in early pregnancy and are one of the most common congenital defects. To fully understand how craniofacial disorders arise, it is essential to characterize gene expression during the patterning of the craniofacia
Externí odkaz:
https://doaj.org/article/8fb52a1254b34d8ba4d504c9a78dcfc6
Autor:
Fu-Tien Liao, Tia Gordon, Chia Chia Liu, Pier Selenica, Yingjie Zhu, Juber Patel, Sarmistha Nanda, Lanfang Qin, Xiaoyong Fu, Andrea Gazzo, Antonio Marra, Juan Blanco-Heredia, Britta Weigelt, Jorge Reis-Filho, C. Kent Osborne, Mothaffar Rimawi, Rachel Schiff, Jamunarani Veeraraghavan
Publikováno v:
Cancer Research. 83:P1-13
Background: The HER2-specific tyrosine kinase inhibitor (TKI) tucatinib (Tuca) recently approved for advanced HER2+ breast cancer is making a move towards the early setting. Given its growing use, resistance is inevitable, as observed in the HER2CLIM
Autor:
Jamunarani Veeraraghavan, Fu-Tien Liao, Tia Gordon, Pier Selenica, Sarmistha Nanda, Lanfang Qin, Yingjie Zhu, Juber A. Patel, Andrea Gazzo, Fabio Stossi, Michael A. Mancini, Carolina Gutierrez, Britta Weigelt, Jorge S. Reis-Filho, C. Kent Osborne, Mothaffar F. Rimawi, Rachel Schiff
Publikováno v:
Cancer Research. 82:LB517A-LB517A
Tucatinib (Tuc) was recently approved for metastatic disease and is moving towards the early setting in HER2+ breast cancer (BC). Given the increasing clinical use of Tuc, resistance will likely soon emerge as a challenge. Here, we explore the yet un
Autor:
Kimberly Linenberger Cortes, Tia Gordon, Cassidy R. Terrell, Adriane B. Randolph, Jenifer Calvert
Publikováno v:
The FASEB Journal. 35
Autor:
Tia Gordon, Haowei Du, Elizabeth J. Bhoj, K Taylor Wild, James R. Lupski, Shalini N. Jhangiani, Daryl A. Scott, Jennifer E. Posey, Elaine H. Zackai
Publikováno v:
Am J Med Genet A
Congenital diaphragmatic hernias (CDH) confer substantial morbidity and mortality. Genetic defects, including chromosomal anomalies, copy number variants, and sequence variants are identified in ~30% of patients with CDH. A genetic etiology is not ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add127543c687372f62b2a6c7c90b6cb
https://europepmc.org/articles/PMC7988837/
https://europepmc.org/articles/PMC7988837/
Publikováno v:
Journal of the American Society of Echocardiography. 27:940-948
Cardiovascular physiologic remodeling associated with athleticism may mimic many of the features of genetic and acquired heart disease. The most pervasive dilemma is distinguishing between normal and abnormal physiologic remodeling in an athlete's he